Co-Founder and CEO
Join Medable at SCOPE Summit 2024
We would love to meet with you at SCOPE! Book a meeting with us to:
- • Learn how we are eliminating many of the biggest process bottlenecks and removing eCOA from the critical path to trial go-live.
- • See a demo of our updated eCOA capabilities that have already begun to shave weeks off build timelines.
- • Hear our plans for 2024 and where we see the power technology has to rapidly accelerate clinical development from protocol to submission.
Don't forget to join our breakfast session or stop by our session in the innovation theater or stop by our booth to learn how digital offerings can improve patient experiences, see the latest industry research, and pickup Medable swag.
Rosen Shingle Creek, Florida- Booth #621
February, 11-14, 2024
Who is Medable?
Medable is on a mission to get effective therapies to people faster. Its digital clinical trials platform enhances speed, scale, and patient access in clinical research, accelerating medicines for thousands of conditions without treatment or cure. Named a Leader in the industry by Everest Group and awarded Best Digital Health Solution by the Galien Foundation, the Medable platform has been deployed in more than 300 trials in 60 countries and 120 languages, serving more than one million patients globally. Medable is a privately held, venture-backed company headquartered in Palo Alto, California, and ranked #398 on the Inc. 5000 in 2023.
Medable is on a mission to get effective therapies to people faster. Its digital clinical trials platform enhances speed, scale, and patient access in clinical research, accelerating medicines for thousands of conditions without treatment or cure. Named a Leader in the industry by Everest Group and awarded Best Digital Health Solution by the Galien Foundation, the Medable platform has been deployed in more than 300 trials in 60 countries and 120 languages, serving more than one million patients globally. Medable is a privately held, venture-backed company headquartered in Palo Alto, California, and ranked #398 on the Inc. 5000 in 2023.
Book a meeting
Request a meeting or demo with our platform experts at our SCOPE booth.
Meet the Medable team
Come by booth #621 to talk with one of our clinical research and trial experts.
Chief Scientific Officer
Pamela Tenaerts
Discuss recent and current research on DCTs and current state of novel clinical trial methodologies.
GENERAL MANAGER, PLATFORM
Colin Weller
Discuss evidence generation, eCOA+, and the future of clinical research
VP, GM, eConsent
Andrew Mackinnon
Medable’s expert on eConsent, AI, and DCT implementation.
Chief Revenue Officer
Jason Rothbart
Discuss clinical trial technology solutions.
EGM, Digital and Decentralized Solutions
Allison Holland
Discuss your DCT and enterprise solutions.
Senior Vice President, Enterprise Sales
Tyler Pugsley
Discuss clinical trial technology solutions for large scale businesses
Business Account Leader
Deanna Coscia
Discuss clinical trial technology solutions.
Executive Director, Business Development
James Thatcher
Discuss CRO business and collaboration.
Intersection of Innovative Development Models and Investment Approaches That Move the Needle at the Portfolio Level
New to SCOPE 2024 - we bring together for the first time, a business-focused panel of strategics from the pharma, investor, healthcare, CRO, and technology start-up communities, to discuss partnership models that drive much needed innovation in clinical trials and impact development at the portfolio level. In this panel we will address the following questions:
- How can Pharma manage risks and investments while continuing to remain at the forefront of drug development, clinical research, and trial technology?
- What alternative business models and risk-sharing partnership can support innovation, in a resource constrained environment?
- Where are the opportunities and the ROI from such partnerships?
- What emerging technologies are showing growth and investment and are moving the needle in clinical research?
- TBD
Tuesday, February 13
3:30 PM EST
30 minutes
FEB
13
The New Frontier:
How Intelligent Automation is Transforming Clinical Deployment
Join us as Colin Weller, GM, Evidence Generation Platform at Medable, unveils how intelligent automation technology reduces clinical trial deployment timelines and accelerates evidence generation at scale as shown in their latest results to reduce trial deployment timelines by 50%. Weller will discuss how Top-10 global pharmaceutical companies are benefiting from Medable’s novel technology, and how the expanded use of digital measures and biomarkers will continue to accelerate clinical development timelines.
- TBD
- Tuesday, February 13
- 8:30 AM EST
- 30 minutes
FEB
